Analysis of CD4⁺CD25⁺ regulatory T cells and Foxp3 mRNA in the peripheral blood of patients with asthma

Abstract

The changes of CD4⁺CD25⁺ regulatory T cells (CD4⁺CD25⁺ Treg) and Foxp3 mRNA in peripheral blood mononuclear cells (PBMCs) from patients with asthma were investigated in order to elucidate the possible roles of CD4⁺CD25⁺ Treg in the development of asthma. The peripheral blood samples were collected from 29 healthy controls (normal control group) and 78 patients with asthma which included 30 patients in exacerbation group, 25 patients in persistent group, and 23 patients in remission group. By using flow cytometry and RT-PCR, the CD4⁺CD25⁺ Treg ratio and Foxp3 mRNA in PBMCs were detected. The CD4⁺CD25⁺ Treg ratio and Foxp3 mRNA in PBMCs of exacerbation and persistent groups were lower than that of remission and normal control group (P<0.05). Although the CD4⁺CD25⁺ Treg ratio and Foxp3 mRNA of remission group also lower than that of normal control group, there was no significant difference between them (P>0.05). As compared with persistent group, exacerbation group had lower CD4⁺CD25⁺ Treg ratio and Foxp3 mRNA (P<0.05). It was indicated that the decrease of CD4⁺CD25⁺ Treg ratio and its function in PBMCs may be responsible for pathogenesis of asthma.

Keywords

asthma / peripheral blood mononuclear cells / CD4⁺CD25⁺ regulatory T cells / Foxp3 mRNA

References

[1] FontenotJ. D., GavinM. A., RudenskyA. Y.. Foxp3 programs the development and function of CD4⁺ CD25⁺ regulatory T cells. Nat Immunol, 2003, 4(4): 330-336

[2] KhattriR., CoxT., YasaykoS. A., et al.. An essential role for Scurfin in CD4⁺CD25⁺T regulatory cells. Nat Immunol, 2003, 4(4): 337-342

[3] HoriS., NomuraT., SakaguchiS.. Control of regulatory T cell development by the transcription factor Foxp3. Science, 2003, 299(5609): 1057-1061

[4] Asthma Group, Respiratory Sub-association, Chinese Medical Association.. Prevention and treatment guidance of asthma. Chin J Tuberc Respir Dis (Chinese), 2003, 26(3): 132-138

[5] OrmandyL. A., HillemannT., WedemeyerH., et al.. Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma. Cancer Res, 2005, 65(6): 2457-2464

[6] SakaguchiS., SakaguchiN., AsanoM., et al.. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol, 1995, 155(3): 1151-1164

[7] ShevachE. M., McHughR. S., PiccirilloC. A., et al.. Control of T-cell activation by CD4⁺CD25⁺ suppressor T cells. Immunol Rev, 2001, 182: 58-67

[8] SakaguchiS., SakaguchiN., ShimizuJ., et al.. Immunologic tolerance maintained by CD25⁺CD4⁺ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev, 2001, 182: 18-32

[9] ThorntonA. M., ShevachE. M.. Suppressor effector function of CD25⁺CD4⁺ immunoregulatory T cells is antigen nonspecific. J Immunol, 2000, 164(1): 183-190

[10] SuhubertL. A., JefferyE., ZhangY., et al.. Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation. J Biol Chem, 2001, 276(40): 37 672-37 679

[11] BrunkowM. E., JefferyE. W., HjerrildK. A., et al.. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet, 2001, 27(1): 68-73

[12] ChatilaT. A., BlaeserF., HoN., et al.. JM2 encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic dysregulation syndrome. J Clin Invest, 2000, 106(12): R75-R81